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Introduction: Laparoscopic adrenalectomy is today considered the standard treatment for benign small
adrenal tumors. An open question is the use of laparoscopy for large adrenal masses because of technical
limitations and increased risk of malignancy. In this study we report our experience in laparoscopic
adrenalectomy for adrenal masses larger than 6 cm.
Methods: Between January 2010 and December 2013 we performed 41 laparoscopic adrenalectomy.
Fourteen of 41 patients (34,1%) were submitted to laparoscopic adrenalectomy for lesion >6 cm in size.
All patients were submitted routinely to radiological and hormonal tests to indentify tumors
characteristics.
Results: The patients treated were 9 male and 5 female, the mean age was 55.6 years (range 38e74). The
mean tumor size was 8.2 cm (range 6e14 cm) and the lesion were localized on right side in 8 patients
and on the left side in 6 patients. The mean operative time was 181 min (range 145e240 min). Mean
blood loss was 90 ml. No conversion to open surgery was required.
Conclusion: Laparoscopic adrenalectomy offers better surgical outcomes than open adrenalectomy. Size
criteria are, at the moment, the main subject discussed for the laparoscopic approach to adrenal tumors.
In fact, size is an important variable in predicting malignancy. This experience and the results of liter-
ature suggest that laparoscopic approach is safe and feasible for adrenal masses larger than 6 cm with a
longer operative time. In presence of local invasion or vascular inﬁltration laparoscopy is contraindicated.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Laparoscopic Adrenalectomy (LA) is today considered the stan-
dard treatment for benign small adrenal tumors. Since the initial
description in 1992 by Gagner et al. [1] retrospective comparison
studies have shown the decrease of the perioperative morbidity,
lower complication rates, less operative blood loss, less post-
operative pain and shorter hospital stay compared with open
adrenalectomy (OA) [2]. An open question instead is the use of
laparoscopy in case of large adrenal masses because of technical
limitations, longer operative time and increased blood loss [3].
Furthermore, tumor size is usually considered an indicator or ma-
lignancy [4] and it is uncertain if the laparoscopic resection of large
potentially malignant adrenal tumors is appropriate due to concern
over incomplete resection, capsular disruption and local recurrence
[5]. In literature different author considered adrenal masses largersa).
by Elsevier Ltd. All rights reservedthan 5, 6 or 7 cm [6,7]. In this study we report our experience in LA
for adrenal masses larger than 6 cm.
2. Methods
In our Department of General and Emergency Surgery at the
University Hospital Policlinico “P. Giaccone” of Palermo between
January 2010 and December 2013 we performed a total of 41 LA. In
this study we review surgical outcome of 14 patients submitted to
LA for adrenal masses larger than 6 cm.
2.1. Preoperative evaluation
Before surgery all patients were submitted routinely to
Computed tomography (CT) scan to study the characteristics and
size of the lesion. Abdominal magnetic resonance imaging (MRI)
was performed for selected patients. A diagnosis of possible adrenal
carcinoma was based on the patients history and radiologic ﬁnd-
ings. Radiological characteristics of malignancy included local
inﬁltration, irregular margins or tumor heterogeneity, venous.
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malignant lesion [8]. Complete hormonal tests were performed
preoperatively to identify functioning tumors. Indication for adre-
nalectomy included: hormone secreting tumors (Cushing's lesion,
aldosteronoma, pheochromocytomas) and all non-functioning
tumors > 4 cm [9]. We excluded from this study this patients
with preoperative radiologic feature of tumor inﬁltration of the
surrounding structures, venous invasion or systemic metastasis. In
these cases we performed OA [10].
2.2. Surgical technique
Laparoscopic adrenalectomies were performed by a trans-
peritoneal ﬂank approach in the lateral decubitus position with an
inclination of 50e60 relative to the operating table which is
broken to extend the space between the last rib and the iliac crest
[11]. We used Veress needle to induce pneumoperitoneum. For
right adrenalectomy we used four trocars in the right subcostal
region. The right lobe of the liver is mobilized by division of
triangular ligament. Than the peritoneum overlying the right ad-
renal gland, in AlbarraneChatelin space, is dissected using har-
monic scalpel. Tissue dissection along the lateral border of the
inferior vena cava allowed the identiﬁcation of the short adrenal
veinwhich was clipped and divide. Then, by dissecting frommedial
to lateral and from inferior to superior the gland was mobilized
until it was completely free. For left-side resection we positioned
three trocars in the left subcostal region. We divided splenocolic
and splenophrenic ligament. The spleen and pancreatic tail were
rotatedmedially. The peritoneal dissectionwas performed until the
left renal vein is reached. We used also diaphragmatic vein like
landmarks for adrenal vein which was clipped and divided. The
resection then proceeded as previously described for the right ad-
renal gland. On the left side we used always Tisseel® for reposi-
tioning splenic-pancreatic block. Drainage was used routinely. At
the end of the procedure the large tumors were positioning in
endo-bag and removed with a sovrapubic mini-laparotomy. Nor
fragmentation of the gland nor capsular disruption was recorded.
All patients received prophylaxis for deep vein thrombosis [12].
3. Results
Fourteen of 41 patients (34.1%) were submitted to LA for a lesion
>6 cm in size. The mean age of these patients was 55.6 years (range
38e74). The patients treated were 9 male and 5 female. Four of
these 14 patients underwent previous abdominal surgery: two
appendectomies, one hysterectomy and one open cholecystectomy
(in this case the tumor was localized in left adrenal gland). The
mean symptom evaluated was abdominal pain, in other two pa-
tients we observed blood hypertension too, in three case hyper-
glycaemia and typical Cushing presentation. The mean tumor size
was 8.2 cm (range 6e14 cm) and the lesion were localized on right
side in 8 patients and on the left side in 6 patients. We didn't
observe bilateral adrenal masses. The mean operative time was
181 min (range 145e240 min) versus 120 min for adrenal masses
smaller than 6 cm. The right and left adrenalectomy mean opera-
tive time was 179 min and 190 min respectively. Mean blood loss
was 90 ml versus 80 ml of LA for small adrenal masses with not
signiﬁcative difference. Only in one case of left adrenalectomy for
an 8 cm large non-functioning adenoma we registered intra-oper-
ative complicationwith bleeding from spleen injury (blood losswas
230 ml). In this case hemostasis was obtained with use of hemo-
static matrix (Floseal®) and blood transfusion was not necessary. In
another recent case of a patients with Cushing's disease due to a
right 12 cm adrenal mass we observed a discrete diffuse bleeding
from peri-renal tissue solved by positioning of Hemopatch®. Noblood transfusion were required. Hemodynamic change with labil
intra-operative blood pressure occurred in one patient with
pheochromocytoma despite adequate preoperative pharmacolog-
ical therapy [13,14]. No conversion to open surgery was necessary.
All 14 patients had their tumor excised via en bloc resection, there
was no capsular disruption during dissection or postoperative
mortality. Mean postoperative hospital stay was 4.2 days (range
3e6 days). Preoperative hormonal tests and the ﬁnal histological
examinations for the 14 adrenal lesions revealed one case of ma-
lignant pheochromocytoma, two case of aldosteronoma, three case
of Cushing's disease, two myelolipoma, ﬁve non-functioning ade-
noma. In a young female patient with clinical and hormonal pre-
sentation of Cushing's disease and pre-operative radiologic features
of adenoma the histological examination revealed an adrenal
cortical cancer. So, two of 14 patients (14.3%) treated hadmalignant
tumors (Table 1). Both patients withmalignant pheochromocytoma
and incidental adrenal cortical cancer were still alive respectively
after 15 and 36 months of follow-up. No local recurrence and port-
side metastasis was noted.
4. Discussion
Since 1992 LA has become the ﬁrst-choice treatment in patients
with small adrenal masses [1]. When comparing with open tech-
nique, LA offers better clinical outcomes, lower less perioperative
morbidity and mortality, shorten hospitalization and better
cosmetic results [2]. Size criteria are, at the moment, the main
subject discussed for the laparoscopic approach ti adrenal lesion. In
fact, size is an important variable in predicting malignancy. Tumor
larger than 6 cm are likely to be malignant, however many adrenal
adenomas are larger than 6 cm. On the bases of the NIH consensus
statement the incidental of adrenal cortical carcinoma is 2% for
lesion <4 cm, 6% for tumors of 41e60 mm in size and 25% for tu-
mors larger than 6 cm [15]. So, if size is the only criterion to choose
the better surgical approach many patients with adrenal benign
masses will have an unnecessary open adrenalectomy. Further-
more, some author suggest that also the patients with benign ad-
renal lesions larger than 5e6 cm should not be treated with LA
because of longer operative time and the elevated risk of bleeding
[16]. Recent records on the other hand, demonstrate that LA for
large adrenal tumors is technically safe and feasible [17e19]. Really,
these limitations for laparoscopic approach to large adrenal masses
depend on the surgeon's experience and skill and the size cannot be
considered as an absolute contraindication to laparoscopy. In our
experiencewith adrenal lesions larger than 6 cm the operative time
is longer than small lesions, but complication rate and bleeding are
similar. Therefore, no patients required conversion to open pro-
cedures. So, the only real risk in treating by laparoscopy this large
tumors is the possibility to treat an unknown adrenal cortical
cancer [20]. A diagnosis of adrenal cortical cancer is based on pa-
tients history and radiological ﬁndings. CT scan and abdominal MRI
can demonstrate signs of malignancy like irregular tumors margin,
local invasion or periadrenal tissue inﬁltration. In these cases
laparoscopic approach is contraindicated [21]. The intra-operative
features indicative of malignant nature of an adrenal lesion
include local ﬁxity, invasion of the pancreas, spleen or upper renal
pole, venous thrombosis or inﬁltration and it is recommended to
convert to open technique [22]. Some authors suggest that the
main limitation during laparoscopic dissection for large and
potentially malign adrenal tumors is incomplete resection and
capsular disruption with increased risk of local recurrence and
intra-abdominal neoplastic dissemination [23]. But these intra-
operative complication are also observed during open surgery. So,
what is most important is the ability of the surgeon to perform a
safe and complete resection.
Table 1
Characteristic of 14 patients with adrenal masses >6 cm. NF: non-functioning; Pheo: pheochromocytoma; ACC: Adrenal cortical carcinoma.
Gender Age (years) Histology Tumor size (cm) Side Operative time (min) Complication Conversion
M 48 Aldosteronoma 9 R 145 e e
F 65 Cushing's disease 6.5 R 240 Bleeding from peri-renal tissue e
M 60 Myelolipoma 11 R 180 e e
F 50 Adenoma, NF 7 R 165 e e
M 38 Adenoma, NF 6.3 L 195 e e
F 38 ACC 12 L 210 e e
M 66 Cushing's disease 8 L 175 e
F 50 Adenoma, NF 8 L 180 Spleen bleeding e
M 62 Adenoma, NF 6.5 R 165 e e
F 74 Malign Pheo. 6.7 L 185 e e
M 53 Aldosteronoma 8.3 L 155 e e
M 65 Cushing's disease 7.6 R 195 e e
M 58 Myelolipoma 14 R 185 e e
M 52 Adenoma, NF 6.8 R 170 e e
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The literature demonstrates that LA shows better surgical out-
comes when compared with open adrenalectomy. Is still debated if
this technique is safe and feasible for large adrenal masses because
of increased risk of malignant lesion. This experience and the re-
sults of literature suggest that LA is safe and feasible for adrenal
masses larger than 6 cm, but in presence of local invasion or
vascular inﬁltration, that are predictive signs of malignancy, LA




Agrusa Antonino: study design and writing.
Romano Giorgio: study design and writing.
Frazzetta Giuseppe: data collections and data analysis.
Chianetta Daniela: data collections and data analysis.
Sorce Vincenzo: data collections and data analysis.
Di Buono Giuseppe: data collections, data analysis and writing.
Gulotta Gaspare: study design.
Funding
Agrusa Antonino and other co-authors have no study sponsor.
Conﬂicts of interest
Agrusa Antonino and other co-authors have no conﬂict of
interest.
References
[1] M. Gagner, A. Lacroix, E. Bolte, Laparoscopic adrenalectomy in Cushing's
syndrome and pheochromocytoma, N Engl. J. Med. 327 (1992) 1033.
[2] D. Hazzan, E. Shiloni, D. Golijanin, O. Jurim, D. Gross, P. Reissman, Laparoscopic
vs open adrenalectomy for benign adrenal neoplasm, Surg. Endosc. 15 (2001)
1356e1358.
[3] M.G. Hobart, I.S. Gill, D. Schweizer, et al., Laparoscopic adrenalectomy for
large-volume (> or ¼ 5 cm) adrenal masses, J. Endourol. 14 (2000) 149e154.
[4] C.H. Liao, S.C. Chueh, M.K. Lai, P.J. Hsiao, J. Chen, Laparoscopic adrenalectomy
for potentially malignant adrenal tumors greater than 5 centimeters, J. Clin.
Endocrinol. Metab. 91 (2006) 3080e3083.[5] P.S. Soon, M.W. Yeh, L.W. Delbridge, C.P. Bambach, M.S. Sywak, B.G. Robinson,
et al., Laparoscopic surgery is safe for large adrenal lesions, Eur. J. Surg. Oncol.
34 (2008) 67e70.
[6] A.N. Dalvi, P.M. Thapar, V.B. Thapar, S.A. Rege, A.A. Deshpande, Laparoscopic
adrenalectomy for large tumours: single team experience, J. Minim. Access
Surg. 8 (4) (2012) 125e128.
[7] O.A. Castillo, G. Vitagliano, F.P. Secin, M. Kerkebe, L. Arellano, Laparoscopic
adrenalectomy for adrenal masses: does size matter? Urology 71 (6) (2008)
1138e1141.
[8] G.P. Bernini, P. Miccoli, A. Moretti, et al., Sixty adrenal masses of large di-
mensions: hormonal and morphologic evaluation, Urology 52 (1998)
920e925.
[9] M. Tanaka, Y. Ono, T. Matsuda, Terachi, et al., Urological laparoscopic surgery
guideline committee, Japanese society of endourology and ESWL: guidelines
for urological laparoscopic surgery, Int. J. Urol. 16 (2) (2009 Feb) 115e125.
[10] Y. Erbil, U. Barbaros, G. Karaman, A. Bozboora, S. Ozarmagan, The change in
the principle of performing laparoscopic adrenalectomy from small too large
masses, Int. J. Surg. 7 (2009) 266e271.
[11] A. Agrusa, G. Romano, G. De Vita, G. Frazzetta, D. Chianetta, G. Di Buono,
G. Gulotta, Adrenal gunshot wound: laparoscopic approach. Report of a case,
Int. J. Surg. Case Rep. 5 (2) (2014) 70e72.
[12] A. Agrusa, G. Romano, G. De Vita, G. Frazzetta, D. Chianetta, G. Di Buono,
G. Gulotta, Laparoscopic adrenalectomy: single centre experience, G. Chir. 34
(Suppl. 1) (2013) 78.
[13] G. Conzo, M. Musella, F. Corcione, M. De Palma, F. Ferraro, A. Palazzo,
S. Napolitano, M. Milone, D. Pasquali, A.A. Sinisi, V. Colantuoni, L. Santini,
Laparoscopic adrenalectomy, a safe procedure for pheochromocytoma. A
retrospective review of clinical series, Int. J. Surg. 11 (2013) 152e156.
[14] G. Conzo, M. Musella, F. Corcione, M. De Palma, N. Avenia, M. Milone, C. Della
Pietra, A. Palazzo, D. Parmeggiani, D. Pasquali, A. Sinisi, L. Santini, Laparoscopic
treatment of pheochromocytomas smaller or larger than 6 cm A clinical
retrospective study on 44 patients. Laparoscopic adrenalectomy for pheo-
chromocytoma, Ann. Ital. Chir. 84 (2012) 417e422.
[15] NIH state-of-the-science statement on management of the clinically inap-
parent adrenal mass (“incidentaloma”), NIH Consens. State Sci. Statements 19
(2002) 1e25.
[16] G. Lal, Q.Y. duh, Laparoscopic adrenalectomy: indications and technique, Surg.
Oncol. 12 (2003) 105e123.
[17] F. Porpiglia, P. Destefanis, C. Fiori, et al., Does adrenal size real affect safety and
effectiveness of laparoscopic adrenalectomy? Urology 60 (5) (2002) 801e805.
[18] G. Ramacciato, P. Mercantini, M. La Torre, F. Di Benedetto, G. Ercolani,
M. Ravaioli, M. Piccoli, G. Melotti, Is laparoscopic adrenalectomy safe and
effective for adrenal masses larger than 7 cm? Surg. Endosc. 22 (2008)
516e521.
[19] G. Pisano, P.G. Calo, S. Piras, U. Pisano, A. Nicolosi, Laparoscopic adrenalectomy
in a case of congenital duplication of the inferior vena cava. Case report, Ann.
Ital. Chir. 84 (2013 Jul 25).
[20] C. Sturgeon, W.T. Shen, O.H. Clark, et al., Risk assessment in 457 adrenal
cortical carcinomas: how much does tumor size predict the likelihood of
malignancy? J. Am. Coll. Surg. 202 (2006) 423e430.
[21] A.A. Gumbs, M. Gagner, Laparoscopic adrenalectomy, Best Pract. Res. Clin.
Endocrinol. Metab. 20 (2006) 483e499.
[22] N. Tsuru, K. Suzuki, T. Ushiyama, S. Ozono, Laparoscopic adrenalectomy for
large adrenal tumors, J. Endourol. 19 (2005) 537e540.
[23] C.P. Lombardi, M. Raffaelli, C. De Crea, M. Boniardi, G. De Toma, L.A. Marzano,
P. Miccoli, F. Minni, M. Morino, M.R. Pelizzo, A. Pietrabissa, A. Renda, A. Valeri,
R. Bellantone, Open versus endoscopic adrenalectomy in the treatment of
localized (stage I/II) adrenocortical carcinoma: results of a multiinstitutional
Italian survey, Surgery 152 (6) (2012 Dec) 1158e1164.
